0001493152-23-005468.txt : 20230217
0001493152-23-005468.hdr.sgml : 20230217
20230217164816
ACCESSION NUMBER: 0001493152-23-005468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230107
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dexter Susan
CENTRAL INDEX KEY: 0001806764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35570
FILM NUMBER: 23643459
MAIL ADDRESS:
STREET 1: C/O SONNET BIOTHERAPEUTICS HOLDINGS, INC
STREET 2: 100 OVERLOOK CENTER
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonnet BioTherapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001106838
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522102141
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 100 OVERLOOK CENTER
STREET 2: SUITE 102
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-375-2227
MAIL ADDRESS:
STREET 1: 100 OVERLOOK CENTER
STREET 2: SUITE 102
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: Chanticleer Holdings, Inc.
DATE OF NAME CHANGE: 20050510
FORMER COMPANY:
FORMER CONFORMED NAME: TULVINE SYSTEMS INC
DATE OF NAME CHANGE: 20000214
4
1
ownership.xml
X0306
4
2023-01-07
0
0001106838
Sonnet BioTherapeutics Holdings, Inc.
SONN
0001806764
Dexter Susan
100 OVERLOOK CENTER, SUITE 102
PRINCETON,
NJ
08540
0
1
0
0
Chief Technical Officer
Common Stock
2023-01-07
4
D
0
14627
D
9040
D
Common Stock
2023-01-07
4
A
0
14627
A
23667
D
On December 14, 2022, the Reporting Person was granted 14,627 restricted stock units to be settled in shares of common stock, par value $0.0001. On January 7, 2023, the 14,627 restricted stock units granted to the Reporting Person were rescinded and canceled. On the same day, the Reporting Person was granted a restricted stock award of 14,627 shares of common stock. The shares in connection with the restricted stock award become fully vested on January 1, 2024, provided the Reporting Person remains in continuous service through such date.
A Form 4 that was filed by the Reporting Person on December 22, 2022, incorrectly included amounts in Column 5 of Table I that did not reflect a 14:1 reverse stock split of the Issuer's common stock, effective September 16, 2022.
Includes unvested restricted stock units.
/s/ John Harry Cross III, power of attorney
2023-02-17